Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Investor Relations Group (IRG) is a full-service investor relations and public relations firm that specializes in representing micro-cap and small-cap companies, with a significant focus on the life sciences, biotech, and healthcare sectors. Founded by Dian Griesel, the firm provides strategic communications, media relations, and investor outreach services to help emerging growth companies gain visibility in the financial community. IRG is known for its expertise in navigating the complexities of the healthcare industry, assisting clients with IPOs, clinical trial announcements, and corporate positioning. The firm eventually evolved into Dian Griesel International (DGI), continuing its specialized focus on high-impact communications for the global business community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Investor Relations Group.